


When Switching Patients to Biosimilars, Communication & Expert Nurses Reduce the Nocebo Effect

New Clinical Trials for Ustekinumab & Denosumab Biosimilars Begin Recruitment

Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks
UnitedHealthcare Designates Avsola, Inflectra Preferred Infliximab Products

FDA Approves New Rituximab Biosimilar & Anakinra to Treat a Rare Disease

Biologics in Rheumatology: Revolution & Perspectives

Patients Demonstrated Good Medication Adherence While Taking Biosimilar Treatment

FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis

Biologics May Prevent Cardiovascular Events in RA Patients
- 1
- 2
- 3
- …
- 33
- Next Page »